DN022150: Clinical Trials

1 trial of DN022150, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow DN022150: new trials by email Literature Review of DN022150 trials Research Report on DN022150

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation
DN022150, Chemotherapy - Pancreatic Cancer
Phase 3Not yet recruitingJiangxi Kvvit Pharmaceutical Co., Ltd.3602026-09-012026-07-08

Conditions studied

Pancreatic Neoplasms (1)

Sponsors

Jiangxi Kvvit Pharmaceutical Co., Ltd. (1)